Dublin, Ireland-based Medtronic completed its second tranche investment in Caesarea, Israel-based Mazor Robotics.
Here are six takeaways:
1. Mazor issued securities representing 3.4 percent of its issued and outstanding share capital on a fully diluted basis at a price per American Depositary Share $21.84.
2. The second tranche investment totals $20 million.
3. The announcement of Mazor X Surgical Assurance Platform on July 12 spurred Medtronic to complete this second tranche investment.
4. Medtronic has now purchased a total of 1.96 million ADS', accounting for 7.27 percent of Mazor's issued and outstanding share capital on a fully diluted basis. This totals $31.9 million.
5. As of June 20, Mazor's cash, cash equivalents and investments reached $47.5 million.
6. After the second equity investment, Mazor's cash, cash equivalents and investments will reach $65 million with a fully diluted share count of about 53.9 million.